B-cell lymphoma/CLL 2 (BCL2) translocation –t(14Over the last two decades, molecular genetic testing has assumed a prominent role in the diagnosis, classification, and clinical management of lymphoma [1]. In some lymphoid and more so in myeloid tumors, a specific genetic abnormality may be...
T-cell lymphoma in Singapore: pathology, clinical findings and association with HTLV-1 antibodies. Histopathology 1992 ; 21 : 101 –113.Sng I, Levin A, Jaffe ES et al. T-cell lymphoma in Singapore: pathology, clinical findings and association with HTLV-1 anti- bodies. Histopathology 1992; ...
The epitranscriptional factor PCIF1 orchestrates CD8+ T cell ferroptosis and activation to control antitumor immunity Article 06 January 2025 HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy Article Open access 02 April 2025 Ma...
Temporal bone pathology of metastatic T-cell lymphoma. Acta Otolaryngol Suppl 1988;447:113-19.KOBAYASHI, K., IGARASHI, M., McBRIDE, R. A., SAITO, R., and KATAURA, A.: Temporal bone pathology of metastatic T-ce11lymphoma. Acta Otolaryngol. 447: 113-119, 1988....
1. Voskoboinik, I., J.C. Whisstock, et al. Perforin and granzymes: function, dysfunction and human pathology.Nat Rev Immunol, 2015. 15(6): p. 388-400. 2. Katsuya, H., et al. Current and emerging therapeutic...
NCCN T-Cell Lymphomas Panel Members Summary of the Guidelines Updates • Peripheral T-Cell Lymphomas (PTCL-1) • Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIAA-INTRO) • T-Cell Large Granular Lymphocytic Leukemia (LGLL-INTRO) ...
近日,陆军军医大学第二附属医院(新桥医院)血液病医学中心第一作者李炘檑、刘帮洞、黄德智博士,马娜丫,通讯作者李琼,饶军副教授和张曦教授在《Chinese Medical Journal》期刊上发表论著“Chidamide triggers pyroptosis in T-cell lymphoblasti...
Nancy L.Harris, inInternational Review of Experimental Pathology, 1992 ADefinitions Many cases ofT celllymphoma are characterized by a polymorphous proliferation of atypicallymphoid cellsof varying size, including small lymphocytes, medium-sized atypical cells, and transformed or bizarre cells, which may ...
axicabtagene ciloleucel; Brexu-cel: brexucabtagene autoleucel; Ide-cel: idecabtagene vicleucel; LBCL: large B cell lymphoma; MCL: mantle cell lymphoma; MDS: myelodysplastic syndrome; MM: multiple myeloma; NSCLC: non-small cell lung cancer; TCL: T cell lymphoma; Tisa-cel: tisagenlec...
T-cell lymphomas are rare and aggressive malignancies associated with poor outcome, often because of the development of resistance in the lymphoma against